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A Restricted Subset of Dendritic Cells Captures
Airborne Antigens and Remains Able to Activate
Specific T Cells Long after Antigen Exposure
primary effector cells, the mast cells, and eosinophils.
Despite recent advances in understanding the pathol-
ogy of asthma, little is known about the mechanisms
leading to the chronicity of airway inflammation resulting
in the disease.
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The development of peptide/MHC tetramers for iden-
tification and isolation of T cells of a single peptideMice sensitized for a Th2 response to Leishmania
specificity represents a major technical advance. TheLACK antigen developed allergic airway inflammation
use of MHC class I tetramers has substantially advancedupon exposure to LACK aerosol. Using multimers of
and altered our understanding of CD8 T cell responsesI-Ad molecules bound to a LACK peptide as probes,
to viral and bacterial infections (Busch et al., 1998; Doh-we tracked the migration of LACK-specific Th2 cells
erty, 1998; Kim et al., 2000; White et al., 1999). Moreto the airways. Elevated numbers of LACK-specific
recently, tetramer reagents have been described for aTh2 cells remained in the airways for 5 weeks after
few MHC class II-restricted T cell epitopes to track anti-the last aerosol. Substantial numbers of DC presenting
gen-reactive CD4 T cells following an immunogenicLACK peptides were found in the airways, but not in
challenge (Gu¨tgemann et al., 1998; Liu et al., 2000; Mal-other compartments, for up to 8 weeks after antigen
herbe et al., 2000; Rees et al., 1999). However, this strat-exposure. These LACK-presenting airway DC ex-
egy has not been adopted to visualize antigen-specificpressed CD11c and CD11b as well as high levels of
CD4 T cells in a mouse model of allergic airway inflam-surface molecules involved in uptake and costimula-
mation.tion. Taken together, our results may explain the
Recently, Malherbe and his collaborators showed thatchronic Th2 airway inflammation characteristic of al-
multivalent peptide/MHC molecules that selectivelylergic asthma.
bind to CD4 T cells reacting to the immunodominant
Leishmania LACK antigen (Julia et al., 1996) could beIntroduction
used to accurately detect antigen-specific CD4 T cells
in single-chain TCR-transgenic mice infected with L.Asthma is a complex chronic inflammatory disease of
major (Malherbe et al., 2000). The Leishmania LACKthe lung characterized by airflow obstruction, airway
antigen has proven to be a particularly useful antigenhyperresponsiveness, and airway inflammation (Wills-
with a single dominant I-Ad restricted epitope in BALB/cKarp, 1999). This inflammatory response is character-
mice (Mougneau et al., 1995).ized by infiltration of the airway wall by mast cells, lym-
Here we describe a mouse model of allergic airwayphocytes, and eosinophils, together with elevation of
inflammation using LACK as the model allergen thatallergen-specific IgE. Past studies have established a
permits us to track, enumerate, and purify allergen-critical role for Th2 cytokines such as IL-4, IL-5, and IL-
responsive CD4 T cells in normal mice without the use13 in the disease process (Coyle et al., 1995; Foster et
of TCR-transgenic T cells.al., 1996; Grunig et al., 1998). Furthermore, abundant
clinical and experimental evidence suggests that T
Resultshelper cells initiate and maintain inflammation in allergic
asthma (Cohn et al., 1997; Gavett et al., 1994; Robinson
LACK-Sensitized BALB/c Mice Challenged with LACKet al., 1992). Through the cytokines they secrete, Th2
Aerosols Exhibit the Hallmarks of Allergiclymphocytes drive the production of allergen-specific
Airway InflammationIgE and orchestrate the recruitment and activation of the
To demonstrate that Leishmania LACK protein could
be used in a model of allergic airway inflammation, we
3 Correspondence: rcoffman@dvax.com (R.L.C.), julia@ipmc.cnrs.fr immunized BALB/c mice i.p. at days 0 and 7 with 10g of
(V.J.)
LACK precipitated with 2 mg of alum. When splenocytes4 These authors contributed equally to this work.
were harvested at day 14 and incubated in vitro with5 Present address: Dynavax Technologies, 717 Potter Street, Suite
100, Berkeley, California 94710. LACK peptide, they proliferated and produced high lev-
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Figure 1. LACK Induces a Strong Th2 Response When Administered with Alum
BALB/c mice were immunized i.p. at days 0 and 7 with 10 g LACK protein in 2 mg of alum. At day 14, mice were exposed to LACK or saline
aerosol for 5 consecutive days.
(A) Serum was isolated at day 14. The presence of LACK-specific IgG1 and total IgE was measured by ELISA in the serum of sensitized and
naive animals. Data represent the mean  SEM of five mice.
(B) The cells from BAL of sensitized, challenged mice were collected at the indicated days after the last LACK or saline aerosol and counted.
Cytospin preparations were stained with Wright Giemsa, allowing differentiation into mononuclear cells, neutrophils, and eosinophils by
standard morphology. Data represent the mean  SEM of five mice.
(C) 5  106 lung cells harvested 5 days after the last aerosol challenge were incubated with 0.25mg/ml of LACK or a recombinant control
protein -OVA in 24-well plates. Cytokine contents in the supernatants were analyzed using ELISA after 72 hr of culture. Data show the
responses of pooled cells from ten mice. One representative experiment (out of three) is shown.
(D) CD4 T cells were enriched from bronchial LN or from lavaged lung derived from a pool of 50 sensitized, challenged mice (2 or 4 days
after the last aerosol, respectively). BAL cells were harvested 7 days after the last aerosol from a pool of 100 mice. 106 CD4 T cell preparations
were incubated with I-Ad/LACK multimers coupled to protein A-Alexa488, CyCR-anti-CD4 mAbs, and PE-anti-(B220, CD8, CD11b, Gr-1, and
CD11c). After gating on CD4 PE T cells, I-Ad/LACK and I-Ad/LACK cells were sorted and 7500 cells were incubated with 8  105 irradiated
APC in the presence of 25 M LACK or in medium alone for 72 hr in 96 U-bottom plates. Supernatants were analyzed for IFN- and IL-4
contents using ELISA or a CT4S assay, respectively. Data show the results of one representative experiment out of three.
els of Th2 cytokines but no detectable IFN- (data not maining elevated for 1 week after the last exposure. In
LACK-sensitized mice challenged with saline for 5 days,shown). LACK-sensitized mice contained high titers of
LACK-specific IgG1 and IgE in their sera as compared the number of mononuclear cells was less elevated than
in LACK-challenged mice 1 day later, and after 2 daysto naive animals (Figure 1A), consistent with the strong
Th2 polarization observed at the T cell level. the number had returned to the level of sensitized, non-
challenged controls.To induce allergic airway inflammation, sensitized
mice were challenged with an aerosol of LACK protein To investigate the capacity of LACK-specific T cells
to migrate in response to aerosol challenges, lung cellsor normal saline as a control on 5 consecutive days.
The cellular content of the broncheoalveolar lavage were isolated after the fifth challenge and stimulated in
vitro with LACK protein, a recombinant control protein(BAL) was analyzed on the indicated days after the fifth
exposure (Figure 1B). BAL cells from naive and from (-OVA), or no antigen (Figure 1C). A relatively polarized
Th2 response including IL-4, IL-5, IL-13, and some IFN-sensitized, but not challenged, mice were used as con-
trols. The number of mononuclear cells and eosinophils was detected in response to LACK stimulation but not
in the control cultures. LACK-specific T cells were puri-dramatically increased upon exposure to LACK chal-
lenges, peaking 3 days after the last aerosol and re- fied by sorting of I-Ad/LACK multimer positive cells from
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the bronchial LN, lung, and BAL of sensitized, chal- LACK-Specific T Cells in the Lung and BAL Are
Activated, Nonapoptotic Cellslenged mice and restimulated in vitro with LACK protein.
The prolonged elevation of I-Ad/LACK cells in the air-The I-Ad/LACK cells produced high levels of the Th2-
ways in the absence of a continued antigen challengespecific cytokines, IL-4 (Figure 1D), IL-5, and IL-13
could have different implications depending on the func-(E.M.H. and V.J., unpublished data), but no IFN- (Figure
tional status of these cells. To determine this, lavaged1D). Of the I-Ad/LACK CD4 T cells, only those from
lung and BAL cells from the same mice were harvestedthe BAL responded to LACK protein, and they also pro-
7 days after the last aerosol and stained with I-Ad/LACKduced a predominantly Th2 response (Figure 1D). Thus,
multimers, anti-CD4 mAbs, annexin-V, and 7-ADD (Fig-BALB/c mice primed for a Th2 response to LACK devel-
ure 3A). In the lung, approximatively one-third of theoped strong Th2-mediated allergic airway inflammation
I-Ad/LACK cells were either apoptotic (Annexin-V) orwhen challenged with LACK aerosol.
necrotic (annexin-V/7-ADD) as compared to fewer
than 10% of the I-Ad/LACK cells. This preferential death
among the antigen-specific T cells was consistent withAerosol Challenge with LACK Increases
a waning immune response to LACK. The frequency ofLACK-Specific CD4 T Cells in the Lung
dying T cells in the BAL, however, was substantiallyThe ability to detect by flow cytometry antigen-specific
lower and was the same for I-Ad/LACK and I-Ad/LACKCD4 T cells responding to an aerosol challenge af-
cells—16% and 14%, respectively. This contrastsforded the opportunity to study the dynamics of a T cell
sharply with CD4 T cells in the BAL of sensitized, non-response in different compartments of the lung. Sensi-
challenged mice, in which 85% were dying cells (datatized mice were sacrificed on the indicated days after
not shown).the fifth aerosol challenge, and cell preparations from
To distinguish whether the I-Ad/LACK cells that per-spleen, bronchial LN, lavaged lung, and BAL cells recov-
sisted in the BAL were active or had matured into quies-ered from the lavaged lungs were enriched for T cells
cent long-term memory cells, BAL cells harvested atand stained with I-Ad/LACK multimers (Figure 2). Cells
various times after antigen aerosol challenge werefrom naive mice and from mice sensitized but not ex-
stained with the I-Ad/LACK multimer and anti-CD69posed to aerosol challenges were prepared as controls
mAbs at various times after antigen challenge. Days 1and similarly stained.
and 35 after the last aerosol were selected as representa-
Five aerosol challenges with LACK protein produced
tive time points and are shown in Figure 3. In naive mice
sizeable increases in I-Ad/LACK cells in the BAL, lung,
in which only few CD4 T cells were detectable and none
and bronchial LN, but not in the spleen of LACK-sensi-
stained with I-Ad/LACK multimers, 20% of the CD4 T cells
tized mice (Figure 2). These increases were observed were CD69. At both 1 and 35 days, the majority of the
both as increases in the total numbers of I-Ad/LACK I-Ad/LACK cells were positive for the activation marker
cells in the organ and as the increased proportion of CD69. This was considerably higher than the fraction of
LACK cells as a percentage of total CD4 T cells. In four CD69 I-Ad/LACK cells at either time point in the BAL
independent experiments, we observed that, between of sensitized (data not shown) or naive mice (Figure 3B).
days 2 and 7 after the last aerosol challenge in sensitized Thus, the I-Ad/LACK T cell population that remained
mice, up to 34-fold and 13-fold more I-Ad/LACK cells significantly elevated in the BAL for at least 5 weeks
were recovered from the BAL (p  0.001) and lung (p  after the last aerosol antigen exposure was a largely
0.01) of sensitized, challenged mice compared to sensi- activated, nonapoptotic population capable of making
tized, nonchallenged controls (Figure 2, right panels). a large effector cytokine response in vitro (Figure 1D).
The total numbers of CD4 T cells in the BAL and lung
increased with similar kinetics but lesser magnitude (p LACK-Presenting APC Remain in the BAL
0.03 and p 	 0.5, respectively), accounting for the 3- to 4 Weeks after the Last Aerosol
5-fold increase in I-Ad/LACK cells when expressed as The persistence of elevated numbers of activated, non-
a percentage of total CD4 T cells (Figure 2, left panels). apoptotic I-Ad/LACK T cells in the airways may result
In the BAL and lung, both the frequency and total num- from the persistence in this compartment of APC pre-
bers of I-Ad/LACK cells began to decline after day 7. senting the dominant LACK epitope. To test this hypoth-
However, most clearly in the BAL, the total number of esis, we have assessed the presence of presented LACK
I-Ad/LACK cells remained significantly elevated as peptide on APC harvested at various times after the last
compared to sensitized, nonchallenged controls (p  aerosol LACK challenge. The capacity of cell popula-
0.02). Even after 5 weeks, the number of I-Ad/LACK tions to retain and present LACK was assayed by the
cells was 4-fold higher in the BAL and 2.5-fold higher ability of cells to stimulate the production of IL-2 by a
in the lung than in sensitized controls. There was also LACK-specific CD4 T cell hybridoma. Sensitized, chal-
a significant (p  0.05) increase in the numbers of I-Ad/ lenged mice were sacrificed at different days after the
LACK cells in the bronchial LN with a 9-fold increase last aerosol, and cell suspensions from their LN, lung,
on day 2, declining slowly thereafter. In the spleen, the and BAL were irradiated and cultured with the LACK-
frequency of I-Ad/LACK cells doubled when mice were specific T cell hybridoma LMR7.5 without the addition
sensitized with LACK, but their proportion and number of LACK peptide in vitro. One day later, supernatants
did not significantly increase (p	 0.7) after aerosol chal- were harvested and their IL-2 content was measured by
lenges with LACK. In conclusion, antigen-reactive T cells immunoassay (Figure 4A). APC isolated from the drain-
persist in the airways for long periods of time after low- ing LN 1 day after the last aerosol stimulated the LMR7.5
T cell hybridoma poorly to secrete IL-2, and this produc-dose aerosol exposures to the antigen.
Immunity
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Figure 2. LACK-Specific T Cells Are Detected in Sensitized, Aerosolized Mice
BAL, lavaged lung, bronchial LN, and spleen cells from naive, sensitized, and sensitized, challenged mice were harvested at the indicated
days after the last aerosol (10 mice per group, 15 mice in case of naive or sensitized only). 106 CD4 enriched T cell preparations from LN,
lung, and spleen, and 106 total BAL cells were stained with I-Ad/LACK multimers coupled to protein A-Alexa488, CyCR-anti-CD4, and a cocktail
of PE-anti-(B220, CD8, CD11b, Gr-1, and CD11c) mAbs. The percentage (left panels) and the number of total CD4 (open dots) and I-Ad/
LACK CD4 T cells (filled dots, right panels) were calculated after gating on viable CD4 PE cells. In the right panels, the data for naive
mice were left out because of the scale. Numbers of I-Ad/LACK T cells in BAL, lavaged lung, LN, and spleen of naive mice were 0.2  102,
3.2  104, 0.5  102, and 3.2  104, respectively. Numbers of CD4 T cells in BAL, lavaged lung, LN, and spleen of naive mice were 2.0 
103, 1.1  107, 1.8  104, and 1.1  107, respectively. Data show the results of one representative experiment out of four.
tion ceased after day 2. APC isolated from the lavaged for at least 35 days and was still detectable at the only
later time point examined, day 57.lungs, however, retained sufficient antigen to stimulate
LMR7.5 up to 6 days after the last antigen challenge, To account for differences in the number of I-Ad class
II cells per well that may account for the different APCalthough with rapidly declining efficiency. In striking
contrast, APC activity remained quite high in the BAL activity (Figure 4A), lung, LN, and BAL cell suspensions
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Figure 3. I-Ad/LACK CD4 T Cells in the Airways Are Nonapoptotic Cells and Exhibit an Activated Phenotype
(A) One week after the last aerosol, CD4 preparations from lavaged lungs and BAL isolated from a pool of ten sensitized mice were incubated
with I-Ad/LACK multimers coupled to protein A-Alexa488, PE-anti-Annexin-V mAbs, and 7-ADD. I-Ad/LACK and I-Ad/LACK populations were
analyzed for the expression of Annexin-V and 7-ADD. Data show the result of one representative experiment (out of two).
(B) BAL cells harvested from a pool of ten sensitized, challenged mice on days 1 and 35 after the last aerosol were incubated with I-Ad/LACK
multimers coupled to protein A-Alexa488, CyCR-anti-CD4, and PE-anti-CD69 mAbs. I-Ad/LACK (thick-lined histograms) and I-Ad/LACK (dotted-
lined histograms) CD4 T cells were analyzed for CD69 expression. Data show the results of one representative experiment out of three.
were stained with anti-I-Ad mAbs, and the percentage tained the capacity to present LACK long after the last
aerosol.and numbers of I-Ad cells were calculated for all time
points (Figure 4B). The normalized IL-2 secretion ex-
pressed as the amount of IL-2 induced per 10,000 I-Ad LACK Peptide Is Presented by the CD11cCD11b
DC Subset in BALcells is shown in Figure 4C. Despite variability in the
frequency of I-Ad cells, especially among the BAL sam- To characterize the APC in BAL that presented the
LACK156-173 peptide in vivo, the BAL cells of sensitized miceples, the results were qualitatively similar to the ones
previously shown in Figure 4A. Thus, LN contained few 1 day after the last aerosol challenge were first analyzed by
flow cytometry for surface markers expressed by B cells,LACK-presenting APC at any time point, and lungs con-
tained LACK-presenting APC for only 1 week after the myeloid, and DC lineages (Figure 5A). Thirty-nine percent
of the cells were CD11cCD11b, 18% CD11cCD11b,last aerosol, whereas MHC class II cells from BAL re-
Immunity
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Figure 4. Antigen-Presenting Cells Loaded
with LACK-Derived Peptides Are Detectable
in BAL Long after the Last Aerosol
Cells were isolated from the BAL, lavaged
lungs, and bronchial LN of sensitized and
sensitized, challenged mice (ten mice per
group) on various days after the last aerosol.
(A) Cells were irradiated and incubated with
105 cells of the LMR7.5 T cell hybridoma in
96 U-bottom plates for 24 hr. IL-2 content
was analyzed by ELISA.
(B) 5 105 cells from BAL, lung, and bronchial
LN were blocked with anti-FcIII/II receptor
mAbs and stained with PE-anti-CD4 and
FITC-anti-I-Ad mAbs before being processed
by flow cytometry. The percentage of I-Ad
cells is shown on various days after the last
aerosol.
(C) The absolute numbers of I-Ad cells were
calculated from the percentage of I-Ad cells
found in (B), and using the absolute numbers,
the IL-2 secretion by LMR7.5 was normalized
to 10,000 class II cells per well. Data show
the results of one representative experiment
out of three.
4.7% CD11cCD11b, and 4% B220CD11cCD11b. same level of IL-2. B220CD11cCD11b cells also be-
came quite efficient APC when LACK peptide wasThese four cell subsets were purified to 97% by cell
sorting (Figure 5A), and the antigen-presenting capacity added, and the CD11cCD11b subset had a weak
but significant APC activity, which could be accountedof each was tested by measuring stimulation of IL-2
secretion by the LACK-specific LMR7.5 T cell hybridoma for by 1% contaminating DC. The relatively greater in-
crease in APC activity with added peptide by the(Figure 5B, left panel). Only the two subsets expressing
the DC marker CD11c spontaneously presented LACK CD11cCD11b and the B220CD11cCD11b cells
demonstrates that they were quite competent APC butpeptide to LMR7.5. Of these, the minor CD11cCD11b
subset was by far the most potent, giving effective retained antigen poorly in vivo. Thus, in vivo, despite
the presence of multiple types of potential APC, onlypresentation with as few as 2000 cells per well. In con-
trast, the CD11cCD11b cells were about 100-fold the restricted subset of DC expressing both CD11c and
CD11b surface antigens was able to retain LACK afterless potent as inducers of T cell activation. The
B220CD11cCD11b and CD11cCD11b subsets did in vivo capture and present it to the T cells one day after
antigen challenge.not present appreciable levels of LACK peptide.
The difference in spontaneous APC activity among
subsets was primarily an indication of the presence of The CD11cCD11b DC in BAL
Are Highly Activated APCprocessed and retained LACK rather than a difference in
potential antigen-presenting activity. When the peptide The different subsets of APC in the BAL of sensitized,
challenged mice were further characterized by flow cy-was added in vitro, all cell subsets induced the activation
of LMR7.5 (Figure 5B, right panel). CD11cCD11b cells tometry after staining with different mAbs directed to
cell surface antigens (Figure 6). CD11cCD11b cellsremained the most potent, requiring five to six times
fewer cells than CD11cCD11b cells to induce the expressed low levels of CD4 and CD8
 but were positive
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Figure 5. The CD11cCD11b DC Subset Captured and Processed LACK In Vivo
(A) BAL cells were harvested from a pool of 100 sensitized mice 1 day after the last aerosol, and CD11c, CD11b, and CD11c/CD11b
expressing cells were sorted. CD11cCD11bB220 cells were sorted after gating on the lymphocyte population. Reanalysis of the purified
population revealed a purity 97%.
(B) The purified APC were incubated with the LMR7.5 T cell hybridoma in the absence (left panel) or presence (right panel) of 5 M LACK
peptide. IL-2 contents of the supernatants were measured 24 hr later by ELISA. Data show the results of one representative experiment out
of three.
for Ly6C, Ly6G (Gr-1), F4/80, and DEC-205 mark- and Ly6G mAbs but were low or negative for all the other
markers tested, suggesting that they were granulocytes.ers. These cells also expressed high levels of IL-3R,
I-Ad, CD40, and CD80, but low levels of CD86. The To confirm this and to distinguish between eosinophils
and neutrophils, we prepared cytospins with the purifiedCD11cCD11b cells were low to negative for CD4 and
CD8
 and expressed lower levels of MHC class II, CD80, CD11cCD11b cells to analyze their morphology after
Giemsa staining. Eosinophils represented 65% of this pop-CD86, CD40, DEC-205, IL-3R
, Ly6C, and Ly6G than
the CD11cCD11b population. ulation, whereas the neutrophils constituted the remaining
35% (data not shown). All B220CD11cCD11b cells ex-CD11cCD11b cells stained brightly with anti-Ly6C
Immunity
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Figure 6. Flow Cytometry Analyses of Cell Surface Antigen Expression on APC Present in BAL 1 Day after the Last Aerosol
After gating on the indicated populations, each subpopulation was analyzed for expression of the indicated cell-surface markers. Representative
FACS analyses are shown after gating on the indicated APC subpopulations. The mean fluorescence intensity is indicated in the right upper
corner of each panel.
pressed the CD19 antigen, confirming that they were only the CD11cCD11b subset was able to spontane-
ously present antigen to the LACK-specific T cell hybrid-B-lymphocytes. They expressed very high levels of MHC
class II molecules but low levels of CD40; were negative oma (Figure 7B, left panel). These cells constituted only
1% of total lung but were approximatively 100 timesfor CD80, CD86, and IL-3R
; and had heterogenous
staining for Ly6C, Ly6G, and DEC-205. Thus, the more effective at retaining and presenting the LACK
antigen. No LACK presentation could be detected fromCD11cCD11b DC were found to be the APC subset
expressing the highest levels of MHC class II, DEC-205, the major APC subset, the CD11cCD11b cells, or the
CD11cCD11b cells.and several costimulation molecules, all important for
optimum uptake and/or presentation of antigen to T cells Exogenously added LACK peptide could be pre-
sented by the CD11cCD11b but not by thein vivo.
CD11cCD11b subset, similar to day 1 post-challenge
BAL cells. Under these conditions, the CD11cCD11bThe CD11cCD11b Cells Retain the Capacity
to Activate Allergen-Specific T Cells cells were again the most potent APC, as demonstrated
by their ability to induce measurable IL-2 with as fewLong after the Last Exposure
To determine the phenotype of the BAL cells that re- as 100 cells per well. Thus, despite the presence of
various APC in the BAL of sensitized, challenged mice,tained LACK peptide for many weeks after antigen expo-
sure, APC subpopulations were isolated 3 weeks after the CD11cCD11bAPC subset was the major source of
presented antigen at early times after antigen challengethe last aerosol from the BAL of sensitized, challenged
mice and tested for their ability to stimulate the LACK- and was also the subset found to retain that capacity
long after the last exposure to the antigen.specific T cell hybridoma (Figure 7). BAL cells were
stained with anti-CD11c and anti-CD11b mAbs, and
subpopulations were isolated by cell sorting (Figure 7A) Discussion
as described in Figure 5. Compared to the 1-day, post-
challenge time point, the total BAL cell number was CD4 Th2 cells are key initiators of the chronic lung
inflammation responsible for atopic asthma, yet to datesubstantially reduced (data not shown), and the propor-
tion of the CD11cCD11b and CD11cCD11b cells it has not been possible to directly track the migration
and expansion of T cells specific for either a naturaldropped to 2% and 1%, respectively, in contrast to the
CD11cCD11b cells, which increased to 40% (Figure or experimental aeroallergen. This report describes a
mouse model of allergic airway inflammation using the7A). Using BAL cells from 100 sensitized and aerosol-
challenged mice, sufficient numbers were isolated to Leishmania LACK antigen as the experimental allergen
in place of the frequently used protein OVA. BALB/cdetermine their ability to present LACK peptide sponta-
neously to LMR7.5. Three weeks after the last aerosol, mice sensitized by i.p. injection of LACK protein plus
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Figure 7. Late after the Last Exposure, the CD11cCD11b Cells Still Present LACK-Derived Peptides
(A) BAL cells were harvested 3 weeks after the last aerosol challenge from a pool of 100 sensitized mice and stained with PE-anti-CD11c and
APC-anti-CD11b. Subsequently, CD11c, CD11b, and CD11c/CD11b-expressing subpopulations were sorted.
(B) Purified APC were incubated with LMR7.5 T cell hybridoma in the absence (left panel) or presence (right panel) of 5 M LACK peptide.
IL-2 content was measured in the supernatant 24 hr later by ELISA. Data show the results of two similar experiments.
ALUM and challenged with low doses of LACK aerosols rescent staining and cell sorting of T cells specific for
this epitope (Malherbe et al., 2000). Previous attemptsdeveloped the expected, strong, polarized Th2 response
with prominent lung eosinophilia and elevated IgE in to track antigen-specific T cells in vivo have either relied
on functional assays to identify cells reacting to antigenvivo. We found that the LACK-specific T cells remained
long after the last aerosol in the airways, while LACK- or have used changes in total CD4 population as an
approximation of the behavior of the antigen-specificloaded DC expressing both the CD11c and CD11b sur-
face antigens persisted a long time in the airways, re- T cells. TCR-transgenic T cells have been used to di-
rectly track antigen-specific T cells (Jenkins et al., 2001),taining their antigen-presenting capacity over that time.
There are two important advantages in using LACK yet the introduction of a large bolus of adoptively trans-
ferred T cells of a single specificity introduces a numberinstead of OVA. LACK has been shown to have a sin-
gle, highly dominant I-Ad-restricted epitope on peptide of limitations and potential artifacts. Visualizing non-
TCR-transgenic, antigen-specific T cells is now possibleLACK156-173 (Mougneau et al., 1995) that accounts for the
majority of the CD4 T cell response to the whole pro- using soluble forms of the natural ligand, the peptide/
MHC complex that is recognized by their TCR. This newtein. The second is that very specific and efficient I-Ad/
LACK multimers have been developed that allow fluo- technology has significantly changed our understanding
Immunity
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of the course of CD8 T cell responses to bacterial and BAL APC proved remarkably long-lived, retaining signifi-
cant, presented LACK156-173 at day 57, the latest timeviral antigens (Doherty, 1998). Here, using multivalent
I-Ad MHC class II molecules linked to the dominant tested. This contrasted sharply with APC in the lung
parenchyma, which rapidly lost the ability to presentLACK156-173 peptide, we have visualized, enumerated,
and purified LACK-specific CD4 T cells to analyze ef- LACK156-173 during the first week after antigen exposure,
and bronchial LN, which were nearly devoid of cellsfector function during a pulmonary immune response
without the use of TCR-transgenic mice. presenting LACK156-173 even 1 day after aerosol exposure.
The long-lived, antigen-presenting capacity of BALSensitization of mice with two i.p. injections of LACK
protein with alum adjuvant increased the number of I-Ad/ cells could be attributed entirely to a subset of DC with
a distinct cell-surface phenotype. The CD11cCD11bLACK T cells in the spleen, lung, bronchial LN, and
BAL. The increase of I-Ad/LACK T cells in the BAL and subset accounted for nearly all of the presented LACK
at 1 day after aerosol challenge and all of the retainedlung prior to any aerosol challenge suggested that some
LACK-specific T cells had acquired a memory/effector antigen at the latest time point analyzed, day 21. The
survival of the CD11cCD11bDC could be attributed tophenotype allowing them to migrate to tissues not di-
rectly exposed to antigen (Reinhardt et al., 2001; Sal- maturation stimuli and feedback signals from activated
naive or memory T cells (Hermans et al., 2000). It is alsolusto et al., 1999). When sensitized mice were chal-
lenged with LACK aerosol daily for 5 days, the possible that incoming migratory CD11cCD11b cells
phagocytose and process apoptotic CD11cCD11bpercentage and number of I-Ad/LACK cells increased
dramatically in BAL, lung, and bronchial LN but not in cells including their LACK content (Inaba et al., 1998).
Alternatively, recent experiments suggest that pre-the spleen, reaching nearly maximum numbers within 2
days and maintaining high levels through day 7 after the formed MHC/peptide fragments can be transferred from
one DC to another (Knight et al., 1998; Smith and delast aerosol. In the BAL and lung, I-Ad/LACK T cells
comprised up to 4%–5% of total CD4 T cells during St. Groth, 1999). We have performed experiments to
estimate the turnover rate of the CD11cCD11b in thethis period. After 1 week, the numbers of I-Ad/LACK
T cells declined several-fold from peak numbers; how- BAL, using the technique of continuous bromodeoxyuri-
dine labeling. Our preliminary results suggested a muchever, as late as 35 days after the last aerosol exposure,
I-Ad/LACK cells remained elevated, as compared to longer life span for CD11cCD11b DC population in
the BAL as compared to LN DC. After 1 week of bromo-sensitized mice, in the airway lumen. This prolonged
elevation of antigen-specific or total CD4T cells has not deoxyuridine treatment, beginning 4 days after the last
aerosol, only 8% of the CD11cCD11bBAL DC popula-been reported in mouse models of airway inflammation,
although Blyth et al. (1998) have reported prolonged tion was labeled, compared to 70% of the LN DC in
the same animals (data not shown).elevation of lymphocyte infiltrates using a mouse model
with OVA as the antigen. In man, however, chronic air- The CD11cCD11b subset was a minor subset of
DC in normal mice (data not shown) but expanded con-way inflammation with CD4 T cells expressing Th2 cy-
tokine mRNA has been shown to be a characteristic siderably in lungs with an ongoing Th2 response. This
subset was markedly reduced again by day 21, whereasfeature of both atopic and nonatopic asthma (Humbert
et al., 1999; Robinson et al., 1992). the CD11cCD11b increased to 40% at this time.
CD11cCD11b pulmonary DC have been previouslyHighly purified I-Ad/LACK T cells from all lung com-
partments produced high levels of the Th2 cytokines shown to turn over rapidly (Holt et al., 1994) and to
migrate readily into the lung-draining LN (Vermaelen etIL-4 (Figure 1D), IL-5, and IL-13 (E.M.H. and V.J., unpub-
lished data), but no detectable IFN- when restimulated al., 2001; Xia et al., 1995).
In contrast to previous reports of antigen-presentingwith LACK in vitro. In the LN and lung, virtually all of the
response to the whole LACK protein was present in DC migrating from the airways to the bronchial LN after
aerosol exposure to a protein antigen (Vermaelen et al.,the I-Ad/LACK subset, showing that responses to the
LACK156-173 epitope encompassed nearly all of the re- 2001; Xia et al., 1995), we found that the LN contained
few LACK-loaded APC. In these reports, however, ani-sponse to the intact protein. The reproducible observa-
tion that I-Ad/LACK T cells purified from the BAL pro- mals had not been sensitized prior to the aerosol expo-
sure, and it is known that such primary aerosol exposureduced cytokines upon LACK stimulation may reflect the
downregulation of TCR expression, as has previously can lead to development of an abortive T cell response
and IgE unresponsiveness (Sedgwick and Holt, 1985;been reported for BAL T cells (Yamaguchi et al., 1999).
Alternatively, it could be due to T cell responses directed Seymour et al., 1998). In contrast, aerosol exposure of
LACK-sensitized mice rapidly produced a polarized Th2to minor LACK epitopes or cells with low affinity to the
dominant LACK epitope. memory response in the lung, which may account for
the very different migration patterns of APC observedThe persistence in the airways of LACK-specific
T cells with an activated phenotype 5 weeks after the last in our study. A second fundamental difference between
the present experiments and the previous studies is theaerosol suggested the possibility of continued antigen
stimulation at these sites. It is likely that long-lived anti- dose of antigen used in the pulmonary challenge. The
dose of LACK protein delivered to the lower respiratorygen is retained in a processed or at least cell-bound
form since inhaled protein antigens disappear from the tract in each of the five exposures in the present experi-
ments was estimated at 200–300 ng, whereas doseslung quite rapidly in vivo (Seymour et al., 1998; Taylor
and Bourne, 1985; Willoughby and Willoughby, 1977). used for previous studies of lung APC migration were
700 g (Vermaelen et al., 2001) or 100 g (Xia et al.,To test this, we investigated whether APC present in
the lung and airways retained LACK156-173 on I-Ad that 1995), doses that far exceed any normally encountered
airborne allergen and may result in unresponsiveness.could be effectively presented. Antigen presentation by
Persistence of Antigen-Presenting DC in Lung
281
(Molecular Probes Inc., Eugene, OR) at the concentration of 0.5The CD11cCD11b DC expressed high levels of sev-
mg/ml in PBS with 8 g of I-Ad/LACK dimers for 30 min at roomeral surface proteins important for APC function, includ-
temperature (Malherbe et al., 2000). The following mAbs were useding I-Ad, CD40, CD80, CD86, and DEC-205. Both the
for stimulation, cell purification, or flow cytometry analysis: 145/
conventional CD11cCD11b pulmonary DC and B cells 2C11, anti-CD3; GK1.5, anti-CD4; 53-6.7, anti-CD8
; M1/70, anti-
could provide highly effective antigen presentation CD11b; RA3-6B2, anti-B220; AMS-32.1, anti-I-Ad; HL3, anti-CD11c;
RB6-8C5, anti-Gr-1; 5B11, anti-IL3R
; 16-10A1, anti-CD80; GL1,when pulsed with LACK156-173 peptide in vitro. However,
anti-CD86; HM40-3, anti-CD40; AL-21, anti-Ly6C; 1D3, anti-CD19;neither population appeared to retain LACK156-173 effi-
2.4G2, anti-FcIII/II receptor; and H1-2F3, anti-CD69. The coupledciently after this in vivo low-dose aerosol challenge,
mAbs were purchased from BD Pharmingen (San Diego, CA), andwhich correlated with their lower expression of
the purified ones used for T cell depletion were prepared at DNAX.
DEC-205. Cl:A3-1, FITC-labeled, anti-F4/80 and NLDC-145, anti-DEC-205
It is difficult to relate the CD11cCD11b cells found mAbs were purchased from Caltag (Burlingame, CA) and Serotec
(Raleigh, NC), respectively.in the BAL of allergic mice to a previously described
subset of DC since they expressed a combination of
In Vitro Restimulation of Lung and I-Ad/LACK CD4 Cellsdifferent markers thought to be characteristic of specific
Lungs were lavaged, the associated bronchial LN were removedsubsets. The CD11cCD11b cells expressed DEC-205
aseptically, and the lungs were forced through a sterile No. 100found on Langerhans cells, and bone marrow-derived,
steel mesh (Tylinter Inc., Mentor, OH) with the piston of a 10 ml
thymic, and some splenic DC (Inaba et al., 1995; Kronin plastic syringe. The cells were lysed with 3 ml of lysis buffer (Sigma
et al., 2000). They also expressed F4/80, which is thought Chemical Co., St Louis, MO) for 3 min and washed with Hanks BSS
solution. 5  106 lung cells were stimulated in 24-well plates into be characteristic of macrophages but was also re-
culture medium containing 0.25 mg/ml of LACK protein. After sortingcently reported to be on the surface of freshly isolated
from lung, LN, or BAL, 7500 I-Ad/LACK and 7500 I-Ad/LACK CD4splenic DC (Leenen et al., 1998). In addition, they stained
cells were incubated with 106 irradiated syngenic splenocytes withbrightly for the granulocyte marker Ly6-G (Gr-1). This
or without LACK protein (0.25 mg/ml) in 96-well flat-bottom plates.
marker has recently been found on murine plasmocytoid The culture medium was RPMI 1640 (JRH Biosciences, Lenexa, KS)
DC, which express B220 but not CD11b and produce with 10% heat-inactivated FCS (Sigma Chemical Co., St Louis, MO),
0.05 mM 2-mercaptoethanol (Sigma), 2 mM L-glutamine (JRH Bio-IFN-
 (Nakano et al., 2001; Asselin-Paturel et al., 2001).
sciences), and penicillin/streptomycin (GIBCO BRL, Gaithers-A DC with very similar properties to the one we describe
burg, MD).here has been reported as a major BAL population in
mice overexpressing GM-CSF (Wang et al., 2000).
IgG1 and IgE Measurements
In conclusion, we have developed a model of allergic Mice were bled at day 14 and LACK-specific IgG1 were determined
airway inflammation in which allergen-specific Th2 cells by ELISA as described (McSorley et al., 1997). Total IgE were quanti-
can be tracked and purified in non-TCR-transgenic tated by ELISA using rat anti-IgE mAbs EM95 as coating antibody
and anti-IgE mAbs NIP-210E coupled to biotin as second antibodymice. Using a sensitive T cell presentation assay, we
as described (Hurst et al., 2001).have identified a unique subset of DC localized in the
airways, which retained and presented the antigen for
Analysis of BAL Cellsa prolonged period of time. These results suggest that
After blood collection, a canula was placed into the trachea, and
the airways are a dynamic compartment where both lung was washed four times with 1 ml of pyrogen-free saline warmed
antigen-presenting DC and memory/effector Th2 cells to 37C. The cells were washed with PBS, resuspended in 200 l,
persist for long periods after exposure to the allergen. and counted using a Bu¨rker-Tu¨rk chamber. For differential BAL cell
counts, cytospin preparations were made and stained with WrightIf these phenomena occur in man, they could account
Giemsa. Per cytospin, 400 cells were counted and differentiatedfor the chronic infiltration of Th2 cells observed in the
into mononuclear cells, neutrophils, and eosinophils by standardairways of people with atopic asthma.
morphology.
Experimental Procedures Purification of Cells
For purification of CD4 T cells, LN and spleen cells were depleted
Mice and Induction of Allergic Airway Inflammation of B220, Mac-1, CD8
, and Gr-1 by negative depletion using
Female BALB/cAnN mice were purchased from Taconic Farms, Inc. sheep anti-rat coated Dynabeads as described (Julia et al., 1996).
(Germantown, NY). All animals were raised under specific pathogen- Lavaged lung cells were enriched for CD4 T cells using a Percoll
free conditions at the DNAX Research Institute animal facility and gradient. After lysing, the cells were washed and resuspended in 6
used at 6 weeks of age. Sensitization was performed by two i.p. ml of 90% Percoll, and a 6 ml layer of 40% Percoll was added
injections of 10 g LACK protein precipitated in 2 mg of aluminum delicately on the top. After centrifugation at 1000 rpm for 30 min,
hydroxide (alum) at days 0 and 7. At day 14, sensitized mice were the cells at the interface were collected.
exposed to a LACK protein (1 mg/ml) aerosol challenge for 30 min on
5 consecutive days. Aerosolization was performed using a Passport Flow Cytometry Analysis
aerosol compressor (Invacare Corporation, Elyria, OH) connected For stainings with I-Ad/LACK multimers, 106 CD4 T cell preparations
to a 6500 cm3 box that served as the deposition chamber for the from LN, spleen, lavaged lung, and BAL cells—all previously blocked
mice. Aerosols were given in groups of a maximum of 50 animals. with anti-FcR mAbs—were stained with 60 g/ml of I-Ad/LACK
Experiments were conducted following protocols approved by the multimers for 30 min at room temperature in PBS supplemented
DNAX animal care and use committee. with 0.5% of BSA. Cells were washed and incubated with cychrome
(CyCR)-anti-CD4 mAbs and with a cocktail of phycoerythrin (PE)-
mAbs: anti-B220, -CD11c, -CD11b, -Gr-1, and -CD8
. LymphocytesReagents and Antibodies
LACK peptide (aa 161–173; SLEHPIVVSGSWD) was purchased from gated by forward- and side-scatter parameters were analyzed on a
FACScalibur flow cytometer (Becton Dickinson, San Jose, CA). ForBio-synthesis, Inc. (Lewisville, TX). LACK and -OVA recombinant
proteins were produced in E. coli and purified as described (Moug- the purification of I-Ad/LACK and I-Ad/LACK cells, LN were har-
vested 2 days after the last aerosol from a pool of 50 sensitized mice.neau et al., 1995). Soluble I-Ad/LACK dimers were produced and
used as described (Malherbe et al., 2000). In brief, staining reagent In brief, CD4 preparations were stained with I-Ad/LACK multimers,
CyCR-anti-CD4 mAbs, and the cocktail of PE-mAbs described abovewas prepared by incubating 1.4 l of Alexa488 coupled to protein A
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and sorted into I-Ad/LACKCD4PE and I-Ad/LACKCD4PE popu- regulation of complex T cell populations responding to bacterial
infection. Immunity 8, 353–362.lations on a high-speed sorter VANTAGE SETLO flow cytometer
(Becton Dickinson). For the purification of I-Ad/LACK and I-Ad/ Cohn, L., Homer, R.J., Marinov, A., Rankin, J., and Bottomly, K.
LACK cells from the lung and BAL, cells harvested from a pool of (1997). Induction of airway mucus production by T helper 2 (Th2)
100 mice, 4 or 7 days after the last aerosol, respectively, were lysed, cells: a critical role for interleukin 4 in cell recruitment but not mucus
blocked, stained with CyCR-anti-CD4 mAbs, and sorted by CD4 production. J. Exp. Med. 186, 1737–1747.
expression. The CD4 were stained with I-Ad/LACK multimers and
Cohn, L., Tepper, J.S., and Bottomly, K. (1998). IL-4-independentthe cocktail of PE-mAbs and sorted into I-Ad/LACKCD4PE and
induction of airway hyperresponsiveness by Th2, but not Th1, cells.I-Ad/LACKCD4PE populations. For sorting of APC, BAL cells
J. Immunol. 161, 3813–3816.were collected from 100 sensitized, challenged mice, blocked, and
Coyle, A.J., Le Gros, G., Bertrand, C., Tsuyuki, S., Heusser, C.H.,stained with PE-anti-CD11c, allophycocyanin (APC)-CD11b, and
Kopf, M., and Anderson, G.P. (1995). Interleukin-4 is required forFITC-anti-B220 mAbs before being processed for flow cytometry.
the induction of lung Th2 mucosal immunity. Am. J. Respir. CellFor apoptosis detection, CD4 T cells were first sorted from the
Mol. Biol. 13, 54–59.BAL of sensitized mice (as described above) and stained with I-Ad/
LACK multimers, PE-Annexin-V, and 7-ADD using the Annexin V-PE Doherty, P.C. (1998). The new numerology of immunity mediated by
apoptosis detection kit provided by BD Pharmingen. virus-specific CD8() T cells. Curr. Opin. Microbiol. 1, 419–422.
Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young,
Cytokine Analysis I.G. (1996). Interleukin 5 deficiency abolishes cosinophilia, airways
Supernatants were analyzed for IL-2, IL-5, IL-10, and IFN- content hyperreactivity, and lung damage in a mouse asthma model. J. Exp.
by ELISA as described (Seymour et al., 1998). IL-4 was detected by Med. 183, 195–202.
a bioassay using the IL-4-dependent CT.4S cell line (donated by
Gavett, S.H., Chen, X., Finkelman, F., and Wills-Karp, M. (1994).Dr. William Paul, National Institutes of Health, Bethesda, MD) as
Depletion of murine CD4 T lymphocytes prevents antigen-induceddescribed (Seymour et al., 1998). Supernatants were analyzed for
airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir.IL-13 content by ELISA using the quantitative mouse IL-13 kit pro-
Cell Mol. Biol. 10, 587–593.vided by R&D Systems, Inc. (Minneapolis, MN).
Grunig, G., Warnock, M., Wakil, A.E., Venkayya, R., Brombacher, F.,
Rennick, D.M., Sheppard, D., Mohrs, M., Donaldson, D.D., Locksley,Detection of APC Presenting LACK
R.M., and Corry, D.B. (1998). Requirement for IL-13 independentlyCells from BAL, lavaged lung, and bronchial LN were resuspended
of IL-4 in experimental asthma. Science 282, 2261–2263.at 8  106 cells/ml, and the indicated numbers of cells were added
to a 96-well U-bottom plate. LMR7.5 T cell hybridoma were added Gu¨tgemann, I., Fahrer, A.M., Altman, J.D., Davis, M.M., and Chien, Y.
to each well, and cellular supernatants were harvested 24 hr later (1998). Induction of rapid T cell activation and tolerance by systemic
and analyzed for IL-2 content by ELISA. In some experiments, LACK presentation of an orally administrated antigen. Immunity 8,
peptide was added in the wells at the concentration of 5M. Alterna- 667–673.
tively, lavaged lungs and bronchial LN were cut into small pieces, Hermans, I.F., Ritchie, D.S., Yang, J., Roberts, J.M., and Ronchese,
digested with collagenase (Gibco-BRL) at 37C for 1 hr, and incu- F. (2000). CD8 T cell-dependent elimination of dendritic cells in
bated with LMR7.5 as described above. This latter method demon- vivo limits the induction of antitumor immunity. J. Immunol. 164,
strated equivalent data. 3095–3101.
Holt, P.G., Haining, S., Nelson, D.J., and Sedgwick, J.D. (1994).Statistics
Origin and steady-state turnover of class II MHC-bearing dendriticTo evaluate the kinetic responses of I-Ad/LACK and total CD4
cells in the epithelium of the conducting airways. J. Immunol. 153,T cells in the various organs as observed in four independent experi-
256–261.ments, a nonparametric ANOVA (Kruskal-Wallis test) was applied.
Humbert, M., Menz, G., Ying, S., Corrigan, C.J., Robinson, D.S.,All tests were performed using the program Instat 3.00. A difference
Durham, S.R., and Kay, A.B. (1999). The immunopathology of extrin-was considered significant when p  0.05.
sic (atopic) and intrinsic (non-atopic) asthma: more similarities than
differences. Immunol. Today 20, 528–533.Acknowledgments
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